open-source database software (OpenClinica LLC)
90
Structured Review
OpenClinica LLC
open-source database software
Open Source Database Software, supplied by OpenClinica LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/open-source+database+and+software/open+source+software/pmc04161312-8-0-0
Average 90 stars, based on 1 article reviews
Open Source Database Software, supplied by OpenClinica LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/open-source+database+and+software/open+source+software/pmc04161312-8-0-0
Average 90 stars, based on 1 article reviews
open-source database software - by Bioz Stars,
2026-09
90/100 stars
Images
1) Product Images from "Innovative Approaches to Clinical Data Management in Resource Limited Settings Using Open-Source Technologies"
Article Title: Innovative Approaches to Clinical Data Management in Resource Limited Settings Using Open-Source Technologies
Journal: PLoS Neglected Tropical Diseases
doi: 10.1371/journal.pntd.0003134
Figure Legend Snippet: Key online resources.
Techniques Used: Software
Related Articles
other:Article Title: Effect of the Ten-valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease and Pneumonia in Infants Younger Than Ten Weeks of Age in Southern Mozambique: A Population-based Prospective Surveillance Study Article Snippet: Background: Mozambique introduced 10-valent-pneumococcal conjugate vaccine (PCV10) in 2013.. We aimed to evaluate the indirect effect of PCV10 on invasive pneumococcal disease (IPD) and clinical severe pneumonia (CSP) in infants aged less than 10 weeks.. Methods: Routine surveillance data for IPD and CSP among admitted infants less than 10 weeks of age were analyzed to compare IPD and CSP incidence using demographic surveillance data from preand post-PCV10 periods. Article Title: Incidence of influenza and other respiratory viruses among pregnant women: A multi‐country, multiyear cohort Article Snippet: Upon enrollment, study staff documented demographic, socioeconomic, and clinical histories using standardized survey instruments into an Software:Article Title: Informatics Infrastructure in a Rural Pediatric Clinical Trials Network: Matching Specific Clinical Research Needs with Best Practices and Industry Guidelines Article Snippet: .. The Article Title: Cerebral oximetry monitoring versus usual care for extremely preterm infants: a study protocol for the 2-year follow-up of the SafeBoosC-III randomised clinical trial. Article Snippet: .. The data collection and management for this study will utilise the Article Title: Capturing Recent Mycobacterium tuberculosis Infection by Tuberculin Skin Test vs. Interferon-Gamma Release Assay. Article Snippet: .. The data collection and management for this paper were performed using OpenClinica Article Title: Tracking SARS-CoV-2 introductions in Mozambique using pandemic-scale phylogenies: a retrospective observational study Article Snippet: .. All data collection forms will be sent to CISM data centre to be double entered into a computerized database in Article Title: Subthreshold Nanosecond Laser Intervention in Intermediate Age-Related Macular Degeneration: Study Design and Baseline Characteristics of the Laser in Early Stages of Age-Related Macular Degeneration Study (Report Number 1). Article Snippet: Purpose: The Laser Intervention in Early Stages of Age-Related Macular Degeneration (LEAD) study is an investigation of the safety and efficacy of subthreshold nanosecond laser treatment to slow the progression of intermediate age-related macular degeneration (AMD).. This report presents the novel study design and baseline characteristics.. Design: Multicenter, double-masked, randomized controlled, medical device feasibility clinical trial. Article Title: Safety and efficacy of dihydroartemisinin–piperaquine for intermittent preventive treatment of malaria in pregnant women with HIV from Gabon and Mozambique: a randomised, double-blind, placebo-controlled trial Article Snippet: Barcelona Institute for Global Health, Hospital Clínic Universitat de Barcelona, Barcelona, Spain (R González PhD, A Figueroa-Romero MSc, L Stoeger MSc, S Sanz MSc, S Méndez MSc, M Piqueras PhD, C Menendez PhD); Centro de Investigação em Saúde de Manhiça, Manhiça, Mozambique (R González, T Nhampossa PhD, A Mendes MD, E Sevene PhD, F Saúte PhD, C Menendez); Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública, Madrid, Spain (R González, A Figueroa-Romero, L Stoeger, S Sanz, C Menendez); Instituto Nacional de Saúde, Ministério de Saúde, Maputo, Mozambique (T Nhampossa); Centre de Recherches Médicales de Lambaréné, Lambaréné, Gabon (G Mombo-Ngoma PhD, M Esen PhD, R Zoleko-Manego PhD, B Lell PhD, L B Dimessa MD); Center for Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine & I Dept of Medicine University Medical Center Hamburg-Eppendorf, Hamburg, Germany (G Mombo-Ngoma, J Mischlinger PhD, Safety and efficacy of dihydroartemisinin–piperaquine for intermittent preventive treatment of malaria in pregnant women with HIV from Gabon and Mozambique: a randomised, double-blind, placebo-controlled trial |
